INBX (Inhibrx Biosciences, Inc.) Stock Market Reviews

crown

search

Read and share opinions on INBX (Inhibrx Biosciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock marke

INBX

Inhibrx Biosciences, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Inhibrx Reports Third Quarter 2025 Financial Results
Nov 14, 2025
Inhibrx Announces Participation in Upcoming Scientific Conferences
Nov 4, 2025
Evaluating Inhibrx Biosciences (INBX) Valuation Following Breakthrough Phase 2 Results for Ozekibart
Oct 26, 2025
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
Oct 23, 2025
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
Oct 22, 2025
Insiders See US$5.42m Investment In Inhibrx Biosciences Jump Last Week
Aug 15, 2025
Inhibrx Reports Second Quarter 2025 Financial Results
Aug 13, 2025
Inhibrx Reports First Quarter 2025 Financial Results
May 14, 2025
Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President
Apr 1, 2025
Inhibrx Biosciences Full Year 2024 Earnings: Beats Expectations
Mar 19, 2025
Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Mar 17, 2025
Inhibrx Prospective Colorectal Cancer Treatment Shows Encouraging Results, Trial Expansion Planned
Jan 21, 2025
Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer
Jan 21, 2025

Reviews